Article abstract
Nature Genetics 39, 168 - 177 (2007)
Published online: 14 January 2007 | doi:10.1038/ng1943
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Ekaterina Rogaeva1,15, Yan Meng2,15, Joseph H Lee3,15, Yongjun Gu1,15, Toshitaka Kawarai1,15, Fanggeng Zou4,15, Taiichi Katayama1, Clinton T Baldwin2, Rong Cheng3, Hiroshi Hasegawa1, Fusheng Chen1, Nobuto Shibata1, Kathryn L Lunetta2, Raphaelle Pardossi-Piquard1, Christopher Bohm1, Yosuke Wakutani1, L Adrienne Cupples2, Karen T Cuenco2, Robert C Green2, Lorenzo Pinessi5, Innocenzo Rainero5, Sandro Sorbi6, Amalia Bruni7, Ranjan Duara8, Robert P Friedland9, Rivka Inzelberg10, Wolfgang Hampe11, Hideaki Bujo12, You-Qiang Song13, Olav M Andersen14, Thomas E Willnow14, Neill Graff-Radford4, Ronald C Petersen4, Dennis Dickson4, Sandy D Der1, Paul E Fraser1, Gerold Schmitt-Ulms1, Steven Younkin4, Richard Mayeux3, Lindsay A Farrer2 & Peter St George-Hyslop1
Abstract
The recycling of the amyloid precursor protein (APP) from the cell surface via the endocytic pathways plays a key role in the generation of amyloid
peptide (A
) in Alzheimer disease. We report here that inherited variants in the SORL1 neuronal sorting receptor are associated with late-onset Alzheimer disease. These variants, which occur in at least two different clusters of intronic sequences within the SORL1 gene (also known as LR11 or SORLA) may regulate tissue-specific expression of SORL1. We also show that SORL1 directs trafficking of APP into recycling pathways and that when SORL1 is underexpressed, APP is sorted into A
-generating compartments. These data suggest that inherited or acquired changes in SORL1 expression or function are mechanistically involved in causing Alzheimer disease.
- Centre for Research in Neurodegenerative Diseases, Department of Medicine, Department of Laboratory Medicine and Pathobiology and Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; and Toronto Western Hospital Research Institute, Toronto, Ontario M5S 3H2, Canada.
- Department of Medicine (Genetics Program), Department of Neurology, Department of Genetics & Genomics, Boston University School of Medicine, Department of Epidemiology and Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts 02118, USA.
- The Taub Institute on Alzheimer's Disease and the Aging Brain and The Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA; and Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York 10032, USA.
- Department of Neuroscience and Department of Neurology, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, Florida 32224, USA; and Department of Neurology, Mayo Clinic Rochester, 200 First Street SW, Rochester, Minnesota 55905, USA.
- Department of Neuroscience, University of Turin, Via Cherasco 15, 10126 Turin, Italy.
- Department of Neurological and Psychiatric Sciences, Centre for Research, Transfer, and High Education on Chronic, Inflammatory, Degenerative and Neoplastic Disorders, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
- Regional Center of Neurogenetics, AS6, 88046 Lamezia Terme (CZ), Italy.
- Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, Florida 33140, USA; and Department of Psychiatry and Department of Behavioral Sciences and Medicine, University of Miami School of Medicine, Miami, Florida 33140, USA.
- Department of Neurology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
- Meir Hospital, Kfar Saba and Rappaport Faculty of Medicine, Technion, Haifa, Israel 47441.
- Department of Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Martinstrasse 52, 20246 Hamburg, Germany.
- Department of Genome Research and Clinical Application (M6), Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
- Department of Biochemistry, Department of Orthopaedic Surgery and The Genome Research Centre, University of Hong Kong, Hong Kong.
- Department of Molecular Cardiovascular Research, Max Delbrueck Center for Molecular Medicine, Robert Roessle Str. 10, D-13125 Berlin, Germany.
- These authors contributed equally to this work.
Correspondence to: Richard Mayeux3 e-mail: rpm2@columbia.edu
Correspondence to: Lindsay A Farrer2 e-mail: farrer@bu.edu
Correspondence to: Peter St George-Hyslop1 e-mail: p.hyslop@utoronto.ca
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Presenilins and Alzheimer disease: the calcium conspiracyNature Neuroscience News and Views (01 Nov 2006)
RESEARCH
Genetic association of ubiquilin with Alzheimer's disease and related quantitative measuresMolecular Psychiatry Original Article
Expanded high-resolution genetic study of 109 Swedish families with Alzheimer's diseaseEuropean Journal of Human Genetics Article Response
See all 10 matches for Research
